A McGill-led team of researchers have made an important discovery shedding light on the genetic basis of a rare skeletal disorder.
PharmaDrug Inc. Completes Debt Restructuring | Psychedelic Invest
PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLD) (“PharmaDrug” or the “Company“), is pleased to announce that it has closed the previously announced debt restructuring (see